Shangjian Bio's Series A Round

Shangjian Bio raised a round of funding on July 27, 2018. Investors include CCB Principal Capital Management.

Shangjian Bio (尚健生物) is an antibody drug developer.…

Articles about Shangjian Bio's Series A Round: